Tempest to Present at Upcoming Investor Conferences

    NEXT STORY
    Apellis Announces Top-Line Results from Phase 3 DERBY and OAKS Studies in Geographic Atrophy (GA) and Plans to Submit NDA to FDA in the First Half of 2022
    PREV STORY
    Oxurion NV Business & Financial Update – H1 2021
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Relievant Medsystems Announces First Patient Enrollment in the INTRACEPT Clinical Study

    SUNNYVALE, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical ...

    author_avatar
    NASDAQ Market News

    Canntab Partners with Leading Surgeon to Conduct Pain Management Trial — CFN Media

    SEATTLE, Dec. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN ...

    author_avatar
    NASDAQ Market News

     Sorrento CEO to Present at Upcoming Investor Conferences

    author_avatar
    NASDAQ Market News